![](https://img2.chinadaily.com.cn/images/202502/06/67a4b71fa310a2ab87b66eaf.jpeg)
Shanghai Henlius Biotech's lung cancer drug gets EU approval
Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, HANSIZHUANG, or serplulimab, has been approved by the European Commission to treat extensive-stage small cell lung cancer for adult …